You searched for metabolic diseases - Page 38 of 64

arthritis pediatric juvenile idiopathic Leuven

News and Trends 13 Mar 2019

Artificial Intelligence Detects Juvenile Arthritis in the Blood

…unpick complex inflammatory diseases in other ways. One way is screening the genome for particular genes linked to these inflammatory diseases, and another is characterizing gut bacteria in the human…

March 13, 2019 - 3 minutesmins - By Jonathan Smith

epigenetics review cambridge epigenetix oryzon1

In Depth 5 Sep 2017

The Next Generation of Genetic Medicine: A Review of Epigenetics

…diseases, but their use as a monotherapy has not been satisfactory.” The efficacy of these drugs has been marred by individual sensitivities to them that are difficult to untangle such…

September 5, 2017 - 9 minutesmins - By Evelyn Warner

Altheia Science gene therapy autoimmune disease

News and Trends 19 Dec 2018

Italian Biotech Raises Big Series A for ‘Gene Therapy 2.0’

Altheia Science, based in Milan, has raised €17M to fund the development of gene therapies for autoimmune diseases with the remarkable potential to be curative. “The success of our fundraising…

December 19, 2018 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 12 May 2023

Cell and gene therapy company NewBiologix exits stealth with $50M

…experience in biotech and cell line development to the new entity. “Our mission is to help biopharmaceutical companies treat some of the most devastating diseases by providing them with innovative…

May 12, 2023 - 3 minutesmins - By Jim Cornall

In Depth 15 May 2019

The Missing Piece in the Microbiome Field

…beyond just cancer immunotherapy to many other diseases, and potentially even to neurodegenerative diseases, which also have an inflammatory component.” The intersection of cancer and the microbiome has attracted multiple…

May 15, 2019 - 7 minutesmins - By Clara Rodríguez Fernández

cognitive disorders syndesi therapeutics 1

News and Trends 1 Feb 2018

New Biotech Launched to Fight Cognitive Impairment Caused by Alzheimer’s

Syndesi Therapeutics has been formed by UCB and a group of investors, including Novo Seeds and V-Bio to develop a group of compounds for cognitive disorders caused by diseases like…

February 1, 2018 - 3 minutesmins - By Alex Dale

Expert Advice 2 Feb 2024

5 biotech career paths where demand is skyrocketing

…an area showing great promise for treating genetic disorders. Their role is crucial in creating and honing methods to manipulate genes within cells, aiming to cure diseases. The marked rise…

February 2, 2024 - 6 minutesmins - By Willow Shah-Neville

In Depth 3 Mar 2020

How Immunotherapy Could Stop and Prevent Type 1 Diabetes

…its potential to treat all sorts of diseases where the immune system is involved, including cancer and neurodegenerative conditions. As autoimmune diseases are directly caused by the immune system, immunotherapies…

March 3, 2020 - 8 minutesmins - By Clara Rodríguez Fernández

News and Trends 17 Aug 2021

Sanofi’s Translate Bio Buyout Shows Growing Hunger for mRNA Technology

…therapies for a range of conditions, including respiratory, liver, and infectious diseases. The company’s €2.7B ($3.2B) buyout, announced by Sanofi earlier this month, seems a tacit acknowledgment of the potential…

August 17, 2021 - 5 minutesmins - By Mark Zipkin

News and Trends 8 Jan 2018

Galapagos Teams up with Dutch Biotech to Edit Fibrosis out of our RNA

Galapagos and ProQR will work together to target fibrosis using a technology to treat genetic diseases without permanent changes to the DNA. A new research collaboration between two biotech companies…

January 8, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

Best in Biotech 30 Apr 2018

The 5 Best-Selling European Drugs of 2017

Biologicals have completely changed the way we treat diseases, and their growth has exploded in the last two decades. Not surprisingly, they took a whopping 7 out of 15 spots…

April 30, 2018 - 7 minutesmins - By Karen O’Hanlon Cohrt

In Depth 11 Nov 2024

Gene editing sector investment struggles: What’s driving the slowdown?

…that the prices are justified due to the fact that they are one-time therapies that will save patients money in the long-term and the rarity of the diseases that they…

November 11, 2024 - 8 minutesmins - By Willow Shah-Neville

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: metabolic diseases

Artificial Intelligence Detects Juvenile Arthritis in the Blood

The Next Generation of Genetic Medicine: A Review of Epigenetics

Italian Biotech Raises Big Series A for ‘Gene Therapy 2.0’

Cell and gene therapy company NewBiologix exits stealth with $50M

The Missing Piece in the Microbiome Field

New Biotech Launched to Fight Cognitive Impairment Caused by Alzheimer’s

5 biotech career paths where demand is skyrocketing

How Immunotherapy Could Stop and Prevent Type 1 Diabetes

Sanofi’s Translate Bio Buyout Shows Growing Hunger for mRNA Technology

Galapagos Teams up with Dutch Biotech to Edit Fibrosis out of our RNA

The 5 Best-Selling European Drugs of 2017

Gene editing sector investment struggles: What’s driving the slowdown?

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!